Pre-Posterior Distributions in Drug Development and Their Properties.

Autor: Grieve AP; Fairholme, Upper Street, Tilmanstone, Kent, UK.

Publikováno v: Pharmaceutical statistics [Pharm Stat] 2024 Nov 25. Date of Electronic Publication: 2024 Nov 25.

Optimising the trade-off between type I and II error rates in the Bayesian context.

Autor: Walley RJ; Statistical Sciences and Innovation, UCB Pharma, Slough, UK., Grieve AP; Statistical Sciences and Innovation, UCB Pharma, Slough, UK.

Publikováno v: Pharmaceutical statistics [Pharm Stat] 2021 Jul; Vol. 20 (4), pp. 710-720. Date of Electronic Publication: 2021 Feb 22.

Quantitative Analysis of White Matter Hyperintensities as a Predictor of 1-Year Risk for Ischemic Stroke Recurrence.

Autor: Sun, Yi¹ (AUTHOR), Xia, Wenping² (AUTHOR), Wei, Ran¹ (AUTHOR), Dai, Zedong¹ (AUTHOR), Sun, Xilin¹ (AUTHOR), Zhu, Jie¹ (AUTHOR), Song, Bin¹ (AUTHOR) songbin@fudan.edu.cn, Wang, Hao¹ (AUTHOR) wang_h@fudan.edu.cn

Publikováno v: Neurology & Therapy. Oct2024, Vol. 13 Issue 5, p1467-1482. 16p.

How to design a dose-finding study using the continual reassessment method.

Autor: Wheeler GM; Cancer Research UK and UCL Cancer Trials Centre, University College London, 90 Tottenham Court Road, London, W1T 4TJ, UK. graham.wheeler@ucl.ac.uk., Mander AP; MRC Biostatistics Unit Hub for Trials Methodology Research, University of Cambridge, Cambridge Institute of Public Health, Forvie Site, Robinson Way, Cambridge Biomedical Campus, Cambridge, CB2 0SR, UK., Bedding A; Roche Pharmaceuticals, Hexagon Place, Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, UK., Brock K; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Cornelius V; School of Public Health, Imperial College London, 68 Wood Lane, London, W12 7RH, UK., Grieve AP; UCB Pharmaceuticals Ltd, 208 Bath Road, Slough, SL1 3WE, UK., Jaki T; Department of Mathematics and Statistics, Fylde College, Lancaster University, Fylde Avenue, Bailrigg, Lancaster, LA1 4YF, UK., Love SB; Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, NDORMS, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK.; MRC Clinical Trials Unit, University College London, 90 High Holborn, London, WC1V 6LJ, UK., Odondi L; Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, NDORMS, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK., Weir CJ; Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences, University of Edinburgh, Nine Edinburgh Bioquarter, 9 Little France Road, Edinburgh, EH16 4UX, UK., Yap C; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Bond SJ; MRC Biostatistics Unit Hub for Trials Methodology Research, University of Cambridge, Cambridge Institute of Public Health, Forvie Site, Robinson Way, Cambridge Biomedical Campus, Cambridge, CB2 0SR, UK.; National Institute for Health Research Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Hills Road, Cambridge Biomedical Campus, Box 401, Coton House Level 6, Cambridge, CB2 0QQ, UK.

Publikováno v: BMC medical research methodology [BMC Med Res Methodol] 2019 Jan 18; Vol. 19 (1), pp. 18. Date of Electronic Publication: 2019 Jan 18.

On sample size calculation in drug interaction trials.

Autor: Meyvisch P; I-BioStat, Universiteit Hasselt, Diepenbeek, Belgium., Ebrahimpoor M; Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Pharmaceutical statistics [Pharm Stat] 2024 Jul-Aug; Vol. 23 (4), pp. 530-539. Date of Electronic Publication: 2024 Feb 14.